Results 111 to 120 of about 23,792 (240)

Characteristics of type 1 diabetes in Northwest China: A multicenter hospital‐based study

Journal of Diabetes Investigation, EarlyView.
This study provided an overview of the characteristics of type 1 diabetes patients in Northwest China, a region with low incidence and limited healthcare resources, highlighting the necessity of enhancing public awareness and long‐term disease education and management. ABSTRACT Objective To comprehensively analyze the characteristics of type 1 diabetes
Yue Zhang, Xiaoning Liu, Xueni Yang, Yujie Zhang, Mengmeng Shang, Limin Tian   +5 more
wiley   +1 more source

Metabolic alterations in pregnant women: gestational diabetes [PDF]

, 2012
Gestational diabetes mellitus (GDM) and controversy are old friends. The impact of GDM on maternal and fetal health has been increasingly recognized.
Fernandes, Rúben, Oliveira, Daniela, Pereira, Joana   +2 more
core   +1 more source

Increase in soluble RAGE following intensive insulin therapy is associated with β‐cell functional improvement and glycemic remission in newly diagnosed type 2 diabetes

Journal of Diabetes Investigation, EarlyView.
Short‐term intensive insulin therapy (SIIT) markedly increased circulating sRAGE levels in newly diagnosed type 2 diabetes. The magnitude of sRAGE elevation was associated with improved β‐cell function and a higher likelihood of short‐term glycemic remission.
Qimou Chen, Fang Wei, Jiajing Ma, Xuhui Li, Boyuan Liu, Yanbing Li   +5 more
wiley   +1 more source

Safety of anagliptin/metformin combination tablets evaluated by non‐inferiority between pre‐ and post‐serum lactic acid levels in Japanese patients with type 2 diabetes and moderate renal impairment (AMELIO STUDY)

Journal of Diabetes Investigation, EarlyView.
To investigate the safety of anagliptin/metformin combination tablets in Japanese patients of type 2 diabetes with moderate renal impairment. This study demonstrates that the fixed‐dose combination of anagliptin and metformin can be used safely in patients with type 2 diabetes complicated by moderate renal dysfunction.
Hiroshi Kajio, Ryotaro Bouchi, Mitsuhisa Komatsu, Masanori Yamazaki, Daisuke Takarabe, Masahide Okamoto, Takahisa Tanaka, Toru Kitazawa, Hisayuki Katsuyama, Yasumichi Mori, Mitsuhiko Noda   +10 more
wiley   +1 more source

Automated bolus advisor control and usability study (ABACUS): does use of an insulin bolus advisor improve glycaemic control in patients failing multiple daily insulin injection (MDI) therapy? [NCT01460446] [PDF]

, 2012
BACKGROUND: People with T1DM and insulin-treated T2DM often do not follow and/or adjust their insulin regimens as needed. Key contributors to treatment non-adherence are fear of hypoglycaemia, difficulty and lack of self-efficacy associated with insulin ...
Bettina Petersen, Christopher G Parkin, Claudia Vogel, David A Cavan, Iain Cranston, Iris Vesper, Jacqueline Ryder, Katharine Barnard, Ralph Ziegler, Robin S Wagner, Walter Koehler   +10 more
core   +1 more source

Effects of switching from MiniMed™ 770G to 780G on continuous glucose monitoring metrics and DTR‐QOL scores: An observational study of Japanese people with type 1 diabetes mellitus

Journal of Diabetes Investigation, EarlyView.
Glycemic outcomes following continuous glucose monitoring. The switch date from the MiniMed™ 770G to the 780G was defined as Week 0, and data were extracted at 2 weeks before the switch (Week −2), as well as at Week 0, Week 12, Week 24, Week 36, and Week 48.
Eri Takagi, Junko Sato, Tatsuhiro Ayame, Shohei Fujikawa, Ryoki Mori, Haruna Yasuda, Azusa Ozaki, Haruki Nagashima, Mami Koshibu, Yuya Nishida, Fuki Ikeda, Hirotaka Watada   +11 more
wiley   +1 more source

Integrating the inputs that shape pancreatic islet hormone release. [PDF]

, 2019
The pancreatic islet is a complex mini organ composed of a variety of endocrine cells and their support cells, which together tightly control blood glucose homeostasis.
Huising, Mark O, Noguchi, Glyn M
core  

Continuous glucose monitoring reveals bimodal glycemic patterns during and outside Capivasertib administration

Journal of Diabetes Investigation, EarlyView.
ABSTRACT Capivasertib, an AKT inhibitor, interferes with insulin signaling and can induce hyperglycemia. In this case, we monitored blood glucose fluctuations using continuous glucose monitoring (CGM) during capivasertib administration. During the administration period, a post‐dose increase in blood glucose was observed, peaking approximately 4 h after
Yuya Suzuki, Takeshi Yamaguchi, Takayasu Uchida, Kimio Matsumura, Nozomi Harai, Kaoru Nagasawa, Yuko Tanabe, Koichi Suyama, Takashi Kadowaki, Yasumichi Mori   +9 more
wiley   +1 more source

Human metabolic adaptations and prolonged expensive neurodevelopment: A review [PDF]

, 2008
1. After weaning, human hunter-gatherer juveniles receive substantial (≈3.5-7 MJ day^-1^), extended (≈15 years) and reliable (kin and nonkin food pooling) energy provision. 2. The childhood (pediatric) and the adult human ...
John R. Skoyles
core   +2 more sources

SGLT-2 Inhibitors: A Novel Mechanism in Targeting Glycemic Control in Type 2 Diabetes Mellitus [PDF]

, 2016
OBJECTIVE: To review the chemistry, pharmacology, pharmacodynamics, pharmacokinetics, clinical efficacy, tolerability, dosing, drug interactions, and administration of canagliflozin, dapagliflozin, and empagliflozin, and comparing the benefit and risk ...
Ahmed-Sarwar, Nabila, Nathan, Kobi T, Werner, Paul M   +2 more
core   +2 more sources